Kyto Technology and Life Science, Inc. announced a private placement for gross proceeds of $2,620,875 on February 4, 2022. The company has issued 3,000,000 class B3 preferred shares at a price of $0.80 per share for gross proceeds of $2,400,000 and 276,094 class B common shares at a price of $0.80 per share for gross proceeds of $220,875. The company has issued securities pursuant to section 4(a)(2).
K2X Technology & Life Science, Inc.
Equities
KBPH
US5015722003
Financial & Commodity Market Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+5.08% | 76.51B | |
-1.21% | 60.79B | |
-0.90% | 41.73B | |
+0.88% | 37.17B | |
-22.96% | 12.88B | |
+9.85% | 9.69B | |
-30.06% | 7.66B | |
+13.10% | 7.38B | |
-6.61% | 7.21B |
- Stock Market
- Equities
- KBPH Stock
- News K2X Technology & Life Science, Inc.
- Kyto Technology and Life Science, Inc. announced that it has received $2.620875 million in funding